Terms: = Leukemia AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
1794 results:
1. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches.
Jiménez C; Garrote-de-Barros A; López-Portugués C; Hernández-Sánchez M; Díez P
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731863
[TBL] [Abstract] [Full Text] [Related]
3. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway.
Zheng H; Wu T; Lin Z; Wang D; Zhang J; Zeng T; Liu L; Shen J; Zhao M; Li JD; Yang M
J Cancer Res Clin Oncol; 2024 May; 150(5):231. PubMed ID: 38703241
[TBL] [Abstract] [Full Text] [Related]
4. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid leukemia Cells In Vitro.
Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
[TBL] [Abstract] [Full Text] [Related]
5. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.
Zhou L; Yin X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):122-127. PubMed ID: 38615173
[TBL] [Abstract] [Full Text] [Related]
6. Different Levels of Therapeutic Strategies to Recover the Microbiome to Prevent/Delay Acute Lymphoblastic leukemia (ALL) or Arrest Its Progression in Children.
Aronica TS; Carella M; Balistreri CR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612738
[TBL] [Abstract] [Full Text] [Related]
7. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.
Gaumond SI; Abdin R; Costoya J; Schally AV; Jimenez JJ
Oncotarget; 2024 Apr; 15():248-254. PubMed ID: 38588464
[TBL] [Abstract] [Full Text] [Related]
9. Decoding the tumour-modulatory roles of LIMK2.
Chong ZX; Ho WY; Yeap SK
Life Sci; 2024 Jun; 347():122609. PubMed ID: 38580197
[TBL] [Abstract] [Full Text] [Related]
10. A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived MLL-rearranged leukemia.
Jassinskaja M; Ghosh S; Watral J; Davoudi M; Claesson Stern M; Daher U; Eldeeb M; Zhang Q; Bryder D; Hansson J
Leukemia; 2024 May; 38(5):1115-1130. PubMed ID: 38555405
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.
Uechi L; Vasudevan S; Vilenski D; Branciamore S; Frankhouser D; O'Meally D; Meshinchi S; Marcucci G; Kuo YH; Rockne R; Kravchenko-Balasha N
NPJ Syst Biol Appl; 2024 Mar; 10(1):32. PubMed ID: 38527998
[TBL] [Abstract] [Full Text] [Related]
12. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
Cornel AM; van der Sman L; van Dinter JT; Arrabito M; Dunnebach E; van Hoesel M; Kluiver TA; Lopes AP; Dautzenberg NMM; Dekker L; van Rijn JM; van den Beemt DAMH; Buhl JL; du Chatinier A; Barneh F; Lu Y; Lo Nigro L; Krippner-Heidenreich A; Sebestyén Z; Kuball J; Hulleman E; Drost J; van Heesch S; Heidenreich OT; Peng WC; Nierkens S
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519054
[TBL] [Abstract] [Full Text] [Related]
13. Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Flynn PA; Long MD; Kosaka Y; Long N; Mulkey JS; Coy JL; Agarwal A; Lind EF
Front Immunol; 2024; 15():1297338. PubMed ID: 38495876
[TBL] [Abstract] [Full Text] [Related]
14. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract] [Full Text] [Related]
15. ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.
Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker.
Wu Z; Liu X; Xie F; Ma C; Lam EW; Kang N; Jin D; Yan J; Jin B
Life Sci; 2024 Apr; 343():122527. PubMed ID: 38417544
[TBL] [Abstract] [Full Text] [Related]
17. Machine Learning-Based Integrated Analysis of PANoptosis Patterns in Acute Myeloid leukemia Reveals a Signature Predicting Survival and Immunotherapy.
Tang L; Zhang W; Zhang Y; Deng W; Zhao M
Int J Clin Pract; 2024; 2024():5113990. PubMed ID: 38322112
[TBL] [Abstract] [Full Text] [Related]
18. A murine model to evaluate immunotherapy effectiveness for human Fanconi anemia-mutated acute myeloid leukemia.
Huang T; Leung B; Huang Y; Price L; Gui J; Lau BW
PLoS One; 2024; 19(1):e0292375. PubMed ID: 38289944
[TBL] [Abstract] [Full Text] [Related]
19. Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate.
Abbas H; Derkaoui DK; Jeammet L; Adicéam E; Tiollier J; Sicard H; Braun T; Poyet JL
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38275765
[TBL] [Abstract] [Full Text] [Related]
20. Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid leukemia.
Shen J; Wen X; Xing X; Fozza C; Sechi LA
Front Cell Infect Microbiol; 2023; 13():1339673. PubMed ID: 38274728
[TBL] [Abstract] [Full Text] [Related]
[Next]